MetCure Therapeutics LLC is a biopharmaceutical company developing novel cancer treatment. Our mission is to discover safe and effective agents specifically targeting those molecules that exert pivotal functions in human cancer cells, particularly in advanced stages. We perform state-of-the art research to develop these drugs in pre-clinical phases, and translate our knowledge into clinical use to enhance standard therapies and improve the survival and quality of life of cancer patients.

Latest News and Events